Evidence map›Paper›PMID 26288355›Full record

ArticleThe Journal of investigative dermatology2015

Suppression of Hyperactive Immune Responses Protects against Nitrogen Mustard Injury.

Liemin Au, Jeffrey P Meisch, Lopa M Das, Amy M Binko, Rebecca S Boxer, Amy M Wen, Nicole F Steinmetz, Kurt Q Lu

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03442088 (An Investigator Initiated Study of Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03442088 phase2completednot on this mapstarted 2018, after this paper: background citation

An Investigator Initiated Study of Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast

TypeinterventionalSponsorUniversity Hospitals Cleveland Medical CenterRan2018 to 2021Enrolled28ConditionsPlaque PsoriasisArmsApremilast
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Buprenorphine blunts inflammatory response and wound progression after skin exposure to nitrogen mustard.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Liemin AuDepartment of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA; Department of Chemical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Jeffrey P MeischDepartment of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA.
Lopa M DasDepartment of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA.
Amy M BinkoDepartment of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA.
Rebecca S BoxerDepartment of Medicine, University of Colorado School of Medicine, Denver, Colorado, USA.
Amy M WenDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Nicole F SteinmetzDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA; Department of Radiology, Case Western Reserve University, Cleveland, Ohio, USA; Department of Material Science and Engineering, Case Western Reserve University, Cleveland, Ohio, USA; Department of Macromolecular Science and Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Kurt Q LuDepartment of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA. Electronic address: kurt.lu@case.edu.
Case Western Reserve University · USUniversity of Colorado Denver · US

Funding

Vitamin D endocrine system and Protection Against Skin TumorlgenesisP30AR039750 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI COOPER, KEVIN D · 1988 to 2015
$9.1M
Amelioration of Vesicant-Induced Skin Injury by High Dose 25-Hydroxyvitamin DU01AR064144 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LU, KURT · 2012 to 2016
$4.2M
NIAMS NIH HHS P30 AR039750NIAMS NIH HHS P30-AR039750NIAMS NIH HHS U01 AR064144NIAMS NIH HHS U01-AR064144
6 · The paper itself

Abstract

DNA alkylating agents like nitrogen mustard (NM) are easily absorbed through the skin and exposure to such agents manifest not only in direct cellular death but also in triggering inflammation. We show that toxicity resulting from topical mustard exposure is mediated in part by initiating exaggerated host innate immune responses. Using an experimental model of skin exposure to NM we observe activation of inflammatory dermal macrophages that exacerbate local tissue damage in an inducible nitric oxide synthase (iNOS)-dependent manner. Subsequently these activated dermal macrophages reappear in the bone marrow to aid in disruption of hematopoiesis and contribute ultimately to mortality in an experimental mouse model of topical NM exposure. Intervention with a single dose of 25-hydroxyvitamin D3 (25(OH)D) is capable of suppressing macrophage-mediated iNOS production resulting in mitigation of local skin destruction, enhanced tissue repair, protection from marrow depletion, and rescue from severe precipitous wasting. These protective effects are recapitulated experimentally using pharmacological inhibitors of iNOS or by compounds that locally deplete skin macrophages. Taken together, these data highlight a critical unappreciated role of the host innate immune system in exacerbating injury following exposure to NM and support the translation of 25(OH)D in the therapeutic use against these chemical agents.

Indexed as

AnimalsBone MarrowCalcifediolFemaleImmunity, InnateLymphopeniaMacrophagesMechlorethamineMiceMice, Inbred C57BLNitric Oxide Synthase Type IICalcifediolMechlorethamineNitric Oxide Synthase Type II

Identifiers

PMID26288355
PMCPMC4648631
OpenAlexW2244017643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.